Rchr
J-GLOBAL ID：200901010460725848   Update date: Sep. 19, 2023

FUJII Chifumi

フジイ チフミ | FUJII Chifumi
Affiliation and department：
Shinshu University Interdisciplinary Cluster for Cutting Edge Research, Institute for Biomedical Sciences , Department of Advanced Medicine for Health Promotion

About Shinshu University Interdisciplinary Cluster for Cutting Edge Research, Institute for Biomedical Sciences , Department of Advanced Medicine for Health Promotion


Job title： Assistant Professor
Research theme for competitive and other funds  (5)：
  • 2023 - 胃腺粘液特異的糖鎖を指標とした予後不良分化型胃がんの診断・治療法開発
  • 2018 - 2021 胃腺粘液糖鎖αGlcNAcの消失による胃がん悪性化の制御機構
  • 2014 - 2017 インフラマソーム構成分子ASCによるがん細胞の転移制御機構の解明
  • 2012 - 2014 アダプタータンパク質ASC下流シグナルを標的とした新規大腸がん治療標的分子の同定
  • 2009 - 2011 新規素材カーボンナノチューブの毒性および発がん性評価
Papers (31)：
  • FUJII Chifumi, NAKAYAMA Jun. Biological Defenses and Regulation of Epithelial Tumor Development by the Gastric Gland Mucus-type Glycan. Shinshu Medical Journal. 2022. 70. 5. 257-269
  • Fujii C (corresponding author), Harumiya S, Sato Y, Kawakubo M, Matoba H, Nakayama J. α1,4-linked N-acetylglucosamine suppresses gastric cancer development by inhibiting Mucin-1-mediated signaling. Cancer Sci. 2022. in press. 11. 3852-3863
  • Yamanoi K, Fujii C (co-first author), Yuzuriha H, Kumazawa M, Shimoda M, Emoto K, Asamura H, Nakayama J. MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung. Histochem. Cell Biol. 2022. 157. 6. 671-684
  • Yuki A, Fujii C (co-first author, corresponding author), Yamanoi K, Matoba H, Harumiya S, Kawakubo M, Nakayama J. Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy. Cancer Sci. 2022. 113. 576-586
  • Kobayashi J, Kawakubo M, Fujii C, Arisaka N, Miyashita M, Sato Y, Komura H, Matoba H, and Nakayama J. Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL. Proc. Natl. Acad. Sci. USA. 2021. 118. e2016469118
ｍore...
Lectures and oral presentations  (39)：
  • αGlcNAc binding to MUC6 enhances suppression of malignant phenotypes of pancreatic cancer cells
    (2022)
  • Phenotypic change of pyloric gland mucin represents potentially malignant biomarker for various neoplasm
    (2022)
  • Regulation of pancreatic cancer malignancy by αGlcNAc and MUC6
    (2022)
  • 淡明細胞型腎細胞癌にて悪性度と相関するアネキシンA1は、紡錘細胞型腎細胞癌でも発現した
    (第109回日本泌尿器科学会総会 2021)
  • MUC6発現は、粘液産生型肺腺癌における予後良好の指標になる
    (第79回日本癌学会学術総会 2021)
ｍore...
Education (3)：
  • 1998 - 2001 Kanazawa University
  • 1996 - 1998 Kanazawa University
  • 1992 - 1996 Kanazawa University
Professional career (2)：
  • 博士(理学) (金沢大学)
  • 修士(理学) (金沢大学)
Work history (8)：
  • 2014/04 - 信州大学学術研究院(医学系)助教 バイオメディカル研究所主担当
  • 2013/04 - 2014/03 Shinshu University Graduate School of Medicine
  • 2007/04 - 2013/03 信州大学医学部医学科助教
  • 2007/04 - 2013/03 Shinshu University School of Medicine, Department of Medicine
  • 2006/09 - 2007/03 信州大学医学部医学科助手
Show all
Association Membership(s) (6)：
日本組織細胞化学会 ,  米国細胞生物学会 ,  日本免疫学会 ,  日本がん転移学会 ,  日本癌学会 ,  日本生化学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM